WallStSmart

Akso Health Group ADR (AHG)vsQuipt Home Medical Corp (QIPT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Quipt Home Medical Corp generates 1685% more annual revenue ($264.97M vs $14.84M). AHG leads profitability with a 0.0% profit margin vs -0.0%. QIPT earns a higher WallStSmart Score of 40/100 (D).

AHG

Avoid

16

out of 100

Grade: F

Growth: 6.0Profit: 2.5Value: 6.0Quality: 7.5
Piotroski: 2/9Altman Z: 7.29

QIPT

Hold

40

out of 100

Grade: D

Growth: 5.3Profit: 2.5Value: 5.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AHGUndervalued (+18.0%)

Margin of Safety

+18.0%

Fair Value

$1.72

Current Price

$1.34

$0.38 discount

UndervaluedFair: $1.72Overvalued
QIPTUndervalued (+8.7%)

Margin of Safety

+8.7%

Fair Value

$3.90

Current Price

$3.65

$0.25 discount

UndervaluedFair: $3.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHG2 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
7.2910/10

Safe zone — low bankruptcy risk

QIPT1 strengths · Avg: 8.0/10
Price/BookValuation
1.6x8/10

Reasonable price relative to book value

Areas to Watch

AHG4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.9%4/10

0.9% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.15B3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

QIPT4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
0.3%4/10

0.3% revenue growth

Market CapQuality
$162.30M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Return on EquityProfitability
-0.1%2/10

ROE of -0.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : AHG

The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.

Bull Case : QIPT

The strongest argument for QIPT centers on Price/Book.

Bear Case : AHG

The primary concerns for AHG are Revenue Growth, EPS Growth, Market Cap.

Bear Case : QIPT

The primary concerns for QIPT are Revenue Growth, Market Cap, Operating Margin.

Key Dynamics to Monitor

AHG profiles as a value stock while QIPT is a turnaround play — different risk/reward profiles.

QIPT carries more volatility with a beta of 0.49 — expect wider price swings.

AHG is growing revenue faster at 0.9% — sustainability is the question.

QIPT generates stronger free cash flow (7M), providing more financial flexibility.

Bottom Line

QIPT scores higher overall (40/100 vs 16/100). AHG offers better value entry with a 18.0% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Akso Health Group ADR

HEALTHCARE · MEDICAL DISTRIBUTION · China

Akso Health Group ADR is a leading innovator in the healthcare sector, focused on delivering advanced medical solutions and comprehensive patient care services. The company harnesses state-of-the-art health technologies to drive growth in areas such as telehealth and personalized medicine, supported by a strong emphasis on research and development. With a resilient business model and a dedicated team, Akso Health Group presents an attractive investment opportunity for institutional investors, poised to capitalize on the ongoing transformation within the healthcare industry.

Visit Website →

Quipt Home Medical Corp

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Quipt Home Medical Corp. The company is headquartered in Wilder, Kentucky.

Want to dig deeper into these stocks?